Completion of a Comprehensive Mouse Knockout Resource
Among the topics discussed at last week's National Cancer Advisory Board (NCAB) meeting, NCI's plan for standardizing the collection and analysis of biological samples was at the top of the list. "When we started this project 3 years ago, none of us recognized the complexities surrounding the policy and technical issues," said Dr. Anna Barker, NCI deputy directory for Strategic Scientific Initiatives. She explained that biorepositories are crucial to cancer research because, "More data is encoded in a person's biological samples than in the rest of their medical record combined." Along with the U.S. Department of Defense, NCI houses one of the largest collections of biological samples in the world, Dr. Barker said. "We have learned that it is time to begin harmonizing our approaches and technologies for all phases of biospecimen collection and management."
Dr. John Niederhuber announced his formal resignation as NCAB chair; Dr. Paul Van Hoff will serve as interim chair. Dr. Niederhuber has been named NCI deputy director for Translational and Clinical Sciences (see Notes). Dr. Andrew von Eschenbach presented Dr. Niederhuber with the NCI Director's Award for his contributions during his tenure as NCAB chair. "John was committed and effective in integrating the NCAB into the leadership of NCI," said Dr. von Eschenbach.
To view an archived webcast of the September 20-21 meeting, go to http://videocast.nih.gov/
Letter of Intent Receipt Date: Oct. 20, 2005. Application Receipt Date: Nov. 22, 2005.
This funding opportunity will use the U01 award mechanism. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3114.
Inquiries: Dr. Jane L. Peterson - email@example.com and Dr. Mark W. Moore - firstname.lastname@example.org
The Obese and Diabetic Intrauterine Environment: Long-Term Metabolic or Cardiovascular Consequences in the Offspring
Letter of Intent Receipt Date: Feb. 16, 2006. Application Receipt Date: March 16, 2006.
This funding opportunity will use the R21 and R01 award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3129.
Inquiries: Dr. Karen Teff - email@example.com; Dr. Cristina Rabadan-Diehl - firstname.lastname@example.org; Dr. Cindy Davis - email@example.com
Exploratory Studies in Cancer Detection, Diagnosis,
Application Receipt Dates: New applications: Oct. 1, 2005; Feb. 1, June 1, and Oct. 1, 2006; Feb. 1, June 1, and Oct. 1, 2007; Feb. 1, June 1, and Oct. 1, 2008. Competing continuation, revised, supplemental applications: Nov. 1, 2005; March 1, July 1, and Nov. 1, 2006; March 1, July 1, and Nov. 1, 2007; March 1, July 1, and Nov. 1, 2008.
This is a renewal of PA-03-003. This funding opportunity will use the R21 award mechanism. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3128.
Inquiries: Dr. James V. Tricoli - firstname.lastname@example.org; Dr. Karl Krueger - email@example.com; Dr. Heng Xie - firstname.lastname@example.org